Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dapagliflozin and Anemia in Patients with Chronic Kidney Disease.
Koshino A, Schechter M, Chertow GM, Vart P, Jongs N, Toto RD, Rossing P, Correa-Rotter R, McMurray JJV, Górriz JL, Isidto R, Kashihara N, Langkilde AM, Wheeler DC, Heerspink HJL. Koshino A, et al. NEJM Evid. 2023 Jun;2(6):EVIDoa2300049. doi: 10.1056/EVIDoa2300049. Epub 2023 May 19. NEJM Evid. 2023. PMID: 38320128 Clinical Trial.
Mechanisms of action of the sodium-glucose cotransporter-2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial.
Sen T, Koshino A, Neal B, Bijlsma MJ, Arnott C, Li J, Hansen MK, Ix JH, Heerspink HJL. Sen T, et al. Among authors: koshino a. Diabetes Obes Metab. 2022 Oct;24(10):1950-1956. doi: 10.1111/dom.14779. Epub 2022 Jun 28. Diabetes Obes Metab. 2022. PMID: 35635326 Free PMC article. Clinical Trial.
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial.
Koshino A, Oshima M, Arnott C, Fletcher RA, Bakris GL, Jardine M, Mahaffey KW, Perkovic V, Pollock C, Heerspink HJL, Neuen BL. Koshino A, et al. Diabetes Obes Metab. 2023 May;25(5):1413-1418. doi: 10.1111/dom.14978. Epub 2023 Feb 6. Diabetes Obes Metab. 2023. PMID: 36655422 Clinical Trial. No abstract available.
Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial.
Koshino A, Neuen BL, Jongs N, Pollock C, Greasley PJ, Andersson EM, Hammarstedt A, Karlsson C, Langkilde AM, Wada T, Heerspink HJL. Koshino A, et al. Cardiovasc Diabetol. 2023 Nov 28;22(1):330. doi: 10.1186/s12933-023-02027-8. Cardiovasc Diabetol. 2023. PMID: 38017482 Free PMC article. Clinical Trial.
Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial.
Koshino A, Neuen BL, Oshima M, Toyama T, Hara A, Arnott C, Neal B, Jardine M, Badve SV, Mahaffey KW, Pollock C, Hansen MK, Wada T, Heerspink HJL. Koshino A, et al. Kidney Int Rep. 2023 Dec 1;9(2):347-355. doi: 10.1016/j.ekir.2023.11.024. eCollection 2024 Feb. Kidney Int Rep. 2023. PMID: 38344715 Free PMC article.
Canagliflozin and iron metabolism in the CREDENCE trial.
Koshino A, Heerspink HJL, Jongs N, Badve SV, Arnott C, Neal B, Jardine M, Mahaffey KW, Pollock C, Perkovic V, Hansen MK, Bakker SJL, Wada T, Neuen BL. Koshino A, et al. Nephrol Dial Transplant. 2024 Sep 20:gfae198. doi: 10.1093/ndt/gfae198. Online ahead of print. Nephrol Dial Transplant. 2024. PMID: 39304530
Identification of circulating microbial DNA and its association with kidney function in patients with diabetic kidney disease.
Linh HT, Oshima M, Sako K, Konishi M, Hayashi D, Sanada H, Yuasa T, Koshino A, Horikoshi K, Minami T, Tsuge S, Tamai A, Nakagawa S, Nishioka R, Zoshima T, Ito K, Mizushima I, Toyama T, Sakai N, Kitajima S, Shimizu M, Wada T, Iwata Y. Linh HT, et al. Among authors: koshino a. Nephrology (Carlton). 2024 Dec;29(12):909-916. doi: 10.1111/nep.14408. Epub 2024 Oct 23. Nephrology (Carlton). 2024. PMID: 39444155
Kidney lesions and risk of cardiovascular events in biopsy-proven diabetic kidney disease with type 2 diabetes.
Shimizu M, Furuichi K, Toyama T, Yamanouchi M, Hayashi D, Koshino A, Sako K, Horikoshi K, Yuasa T, Tamai A, Minami T, Oshima M, Nakagawa S, Kitajima S, Mizushima I, Hara A, Sakai N, Kitagawa K, Yoshimura M, Hoshino J, Ubara Y, Iwata Y, Wada T. Shimizu M, et al. Among authors: koshino a. Clin Exp Nephrol. 2024 Oct 28. doi: 10.1007/s10157-024-02576-6. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 39466582
Effects of d-alanine Intake on Amino Acid Metabolism and Kidney Function in Healthy Adults: A Multicenter, Randomized Pilot Study.
Oshima M, Toyama T, Toyama T, Nakade Y, Tokumaru T, Sako K, Kajikawa S, Hayashi D, Sanada H, Yuasa T, Koshino A, Horikoshi K, Minami T, Tsuge S, Tamai A, Nakagawa S, Nishioka R, Zoshima T, Ito K, Kitajima S, Mizushima I, Hara A, Sakai N, Shimizu M, Mita M, Iwata Y, Wada T. Oshima M, et al. Among authors: koshino a. Curr Dev Nutr. 2024 May 23;8(7):103787. doi: 10.1016/j.cdnut.2024.103787. eCollection 2024 Jul. Curr Dev Nutr. 2024. PMID: 39045146 Free PMC article.
35 results